More on NSRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.07 |
|
|||
| Open | $2.93 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $3.10 | ||||
| Day Low | $2.93 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 6,770 | ||||
- Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
- Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
- Form 4 Nasus Pharma Ltd For: Jun 17 Filed by: Teleman Dan Benjamin
- Nasus Pharma (NSRX) Reiterated at Market Outperform by Citizens
- Form 6-K Nasus Pharma Ltd For: Jun 09
- Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron
- Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)
- Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
- Form S-8 Nasus Pharma Ltd
- Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.
Entities mentioned with NSRX
- Twitter | View Related Stories »
- IPO | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- F1 | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Show More...
